Close

Now Playing:

The biotechnology company Amgen produces two drugs for anemia that have earned the company billions of dollars. But new findings could result in strong warnings being placed on the drugs. Amgen CEO Kevin Sharer talked about his company's situation with Kai Ryssdal.